Self-Reported Asthma Prevalence and Control Among Adults --- United States, 2001
Asthma is a chronic illness that has been increasing in prevalence in the United States since 1980 (1). In 2000, asthma accounted for 4,487 deaths, approximately 465,000 hospitalizations, an estimated 1.8 million emergency department (ED) visits, and approximately 10.4 million physician office visits among persons of all ages (2). To provide prevalence data for state and local health department asthma programs, the Behavioral Risk Factor Surveillance System (BRFSS) collects data each year from the 50 states, the District of Columbia, and three U.S. territories. This report summarizes asthma prevalence data for adults collected from the 2001 BRFSS survey and from the eight states that used the adult asthma history module. Findings from BRFSS indicate that approximately 7.2% of U.S. adults have current asthma. ED visits for asthma varied more than any other characteristic among the eight states that used the adult asthma history module. In Mississippi, 67.3% of respondents with current asthma reported no ED visits during the preceding 12 months, compared with 87.6% in Washington state. Continued use of the BRFSS asthma prevalence questions and the asthma history module will allow state health departments to monitor trends in asthma prevalence and control and to direct public health asthma interventions.
BRFSS is a state-based, random-digit--dialed survey of the noninstitutionalized civilian U.S. population aged >18 years; the survey collects information about modifiable risk factors for chronic diseases and other leading causes of death (3). In 2001, two asthma questions were used as part of the core survey by the 50 states, the District of Columbia, Guam, Puerto Rico, and the Virgin Islands. Lifetime asthma was defined as answering "yes" to the question, "Have you ever been told by a doctor, nurse, or other health professional that you have asthma?" Current asthma was defined as answering "yes" to the lifetime question and to the question, "Do you still have asthma?" Weighted prevalence estimates and 95% confidence intervals (CIs) were calculated by using SUDAAN to account for the complex survey design (4).
The median response rate for all 54 BRFSS reporting areas was 51.1% (range: 33.3% [New Jersey]--81.5% [Puerto Rico]) (5). The overall prevalence of lifetime asthma among adults was 11.0% (95% CI = 10.8%--11.2%) (n = 204,797). Lifetime asthma prevalence from all 54 reporting areas ranged from 7.5% in Guam to 19.6% in Puerto Rico. Among the 50 states, lifetime asthma ranged from 8.4% in Nebraska to 13.3% in Nevada. During 2001, an estimated 15.1 million adults in the United States and the District of Columbia had current asthma; the overall prevalence was 7.2% (95% CI = 7.0%--7.4%). Current asthma prevalence from all 54 reporting areas ranged from 3.5% in Guam to 9.5% in Puerto Rico (Table 1). Among the 50 states, current asthma prevalence ranged from 5.3% (Louisiana and South Dakota) to 9.5% (Massachusetts). Current asthma was higher among persons who were multiple race and non-Hispanic (12.2%), followed by non-Hispanic blacks (8.5%), non-Hispanic whites (7.2%), other race and non-Hispanic (5.9%), and Hispanics (5.7%).
For this report, seven questions (of the nine questions in the asthma history module) were used to measure the level of asthma control in respondents with current asthma. Respondents were asked to report the number of visits to an ED, urgent (unscheduled) doctor visits, or routine check-ups; the number of days they could not perform their usual activities, had trouble with sleep, or had asthma symptoms; and whether they had an asthma attack or episode during the preceding 12 months.
The overall current asthma prevalence for the eight states that used the module was 7.7% (95% CI = 7.3%--8.1%) (Table 2). Current asthma prevalence varied from 5.3% (South Dakota) to 9.0% (Michigan). Among respondents with current asthma, 82.7% reported no visits to an ED during the preceding 12 months; 71.0% reported no urgent visits to a physician; and 54.4% reported routine check-ups for asthma during the preceding 12 months. An estimated 71.6% of respondents with current asthma reported no days of activity limitation, 60.9% reported no days of disturbed sleep, and 21.8% reported having no symptoms during the preceding 30 days. An estimated 47.2% of respondents with current asthma reported no asthma attack or episode during the preceding 12 months. The control characteristics presented were configured so high values represent positive aspects of asthma management. Over time, improved asthma management would result in increased values on each of the seven control characteristics.
On each of the seven asthma-control questions, several states were above or below the CI for the eight-state total. South Dakota was above the CI on six of seven questions, indicating above-average asthma control. Michigan, with the highest current asthma prevalence in the eight states, was within the eight-state total CI on all questions, indicating an average level of asthma control among residents with current asthma.
Reported by: L Rhodes, MPH, JE Moorman, MS, SC Redd, MD, DM Mannino, MD, Div of Environmental Hazards and Health Effects, National Center for Environmental Health, CDC.
Asthma is a multifactorial lung disease that causes wheezing, shortness of breath, coughing, and chest tightness. It is often associated with familial, allergenic, socioeconomic, psychological, and environmental factors (6,7). Asthma affects proportionately more children than adults, women than men, and nonwhites than whites (1). Morbidity and mortality can be partly preventable with better medical, environmental, and self management.
The 2001 BRFSS lifetime prevalence estimate (11.0%) was slightly higher than the 2000 BRFSS lifetime estimate (10.5%). This difference might be an actual increase in prevalence or might be associated with a minor change in question wording in 2001. The current asthma prevalence in 2001 (7.2%) was the same as in 2000. The findings in this report indicate no consistent regional pattern in asthma prevalence and some variability among the states. Possible reasons for this variability include demographic, socioeconomic (e.g., income and education levels), and environmental factors (e.g., outdoor air pollution and climate), physician diagnostic procedures, or data-collection practices. In 2001, current asthma prevalence estimates were comparable with 2000 BRFSS estimates for whites, blacks, and persons of other races. However, the change in the positioning of the race and ethnicity questions on the BRFSS core survey and the addition of a multiple race question could have affected the asthma prevalence estimates when both race and ethnicity are considered.
The findings in this report are subject to at least three limitations. First, the median response rate for BRFSS was low (51.1%); however, asthma prevalence is similar to estimates in other surveys with higher response rates (e.g., National Health Interview Survey). Second, BRFSS does not measure asthma prevalence among institutionalized adults, the military, children aged <18 years, and residents without telephones; the percentage of households with telephones ranged from 87% (Mississippi) to 98% (Massachusetts) (8). Asthma prevalence in households without telephones might be different than in those with telephones. Finally, the validity of self-reported asthma status in BRFSS is unknown. BRFSS case definitions include respondents who have been told by a physician they have asthma; either the physician's diagnosis or the respondent's recall of that diagnosis might be inaccurate. A 1993 review of asthma questionnaires reported a mean sensitivity of 68% (range: 48%--100%) and a mean specificity of 94% (range: 78%--100%) when self-reported asthma was compared with a clinical diagnosis of asthma (9).
Use of BRFSS asthma lifetime and current prevalence questions allows state health departments to monitor trends in asthma prevalence and to direct asthma management. Combined with the existing adult asthma history module, health departments can examine detailed asthma characteristics within their states. BRFSS remains the only comprehensive source of state-level surveillance data for asthma and other chronic diseases.
This report is based on data contributed by state BRFSS coordinators.
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to email@example.com.
Page converted: 5/1/2003
This page last reviewed 5/1/2003